US Patent 9980961 Pyruvate kinase activators for use in therapy
Patent 9980961 was granted and assigned to Agios Pharmaceuticals on May, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 12 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+94 characters)
Article
Patent abstract
Described herein are methods for using compounds that activate pyruvate kinase.
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Lenny Dang0
Shin-San Michael Su0
Edits on 19 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09980961 Pyruvate kinase activators for use in therapy US Patent 9980961 Pyruvate kinase activators for use in therapy
Infobox
Patent Number
099809610
Patent Number
99809610
Edits on 26 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
099809610
Date of Patent
May 29, 2018
0Patent Application Number
155834120
Date Filed
May 1, 2017
0Patent Primary Examiner
Edits on 20 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09980961 Pyruvate kinase activators for use in therapy
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09980961
Date of patent
May 29, 2018
Patent application number
15583412
Date Filed
May 1, 2017
Patent primary examiner
Find more entities like US Patent 9980961 Pyruvate kinase activators for use in therapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
